This article is more than 5 years old. Information may no longer be current.

IOL implantation may be beneficial treatment for congenital cataracts

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN DIEGO — IOL implantation may be a safe and efficacious treatment option for patients with congenital cataracts, a presenter said here.

Abhay R. Vasavada, MS, FRCS, an OSN Asia-Pacific Edition Editorial Board Member, told colleagues at the American Society of Cataract and Refractive Surgery meeting that 8% to 10% of roughly 270,000 children in India who are blind owe their lack of vision to cataracts.

A prospective, randomized, controlled study assessed 60 pseudophakic eyes and 60 aphakic eyes undergoing bilateral cataract surgery.

"Primary intraocular implantation gave a better and safe outcome in these children with bilateral cataracts," he said.

Visual axis obscuration and synechiae formation did not differ between pseudophakic and aphakic eyes at the 4-year follow-up. However, the incidence of glaucoma was significantly higher in aphakic eyes (P < .03), while visual acuity improvements were significantly higher in pseudophakic eyes (P < .001).

Dr. Vasavada cautioned young surgeons to practice IOL implantation in older children initially and emphasized the need for global awareness in order to facilitate early detection.

• Disclosure: Dr. Vasavada does not have any relevant financial disclosures.